Current therapy of interstitial pneumonia associated with systemic scleroderma
A significant progress has been made in recent years in management of severe systemic scleroderma (SSD) manifestations, such as Raynaud’s phenomenon, renal crisis, and pulmonary arterial hypertension, subsequently improving survival and quality of life. At the same time, treatment algorithms for int...
Main Author: | L. P. Ananieva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2020-11-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2955 |
Similar Items
-
Оценка краткосрочной динамики общего числа В-лимфоцитов на фоне лечения ритуксимабом больных системной склеродермией
Published: (2018-06-01) -
CLINICAL IMPORTANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA
by: T A Nevskaya, et al.
Published: (2002-02-01) -
Сложности в диагностике системной склеродермии на примере клинического случая
by: Eugenia Golubkina, et al.
Published: (2019-06-01) -
A case of localized bullous scleroderma
by: A. L. Bakulev, et al.
Published: (2017-08-01) -
SECONDARY PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC DISEASES OF CONNECTIVE TISSUE
by: N. A. Shostak, et al.
Published: (2016-01-01)